These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. [Interviews with a young boy with Wilson's disease. Relation of the patient with copper and the physicians]. Aubry J Arch Fr Pediatr; 1967 Jan; 24(1):104-5. PubMed ID: 6031446 [No Abstract] [Full Text] [Related]
44. Cytopenias secondary to copper depletion complicating ammonium tetrathiomolybdate therapy for Wilson's disease. Karunajeewa H; Wall A; Metz J; Grigg A Aust N Z J Med; 1998 Apr; 28(2):215-6. PubMed ID: 9612534 [No Abstract] [Full Text] [Related]
45. Chelating agents in the treatment of hepatolenticular degeneration (Wilson's disease). BLATTNER RJ J Pediatr; 1958 Jun; 52(6):758-61. PubMed ID: 13550045 [No Abstract] [Full Text] [Related]
46. Preparation of triethylenetetramine dihydrochloride for the treatment of Wilson's disease. Dixon HB; Gibbs K; Walshe JM Lancet; 1972 Apr; 1(7755):853. PubMed ID: 4111619 [No Abstract] [Full Text] [Related]
47. [MRI of Wilson's disease. Tissue differentiation of intracerebral lesions]. Dörnemann H; Petsch R; Braitinger S Rofo; 1987 Nov; 147(5):570-1. PubMed ID: 2825298 [No Abstract] [Full Text] [Related]
48. [Association of an uncombable hair syndrome and Wilson's disease]. Gonin J; Pepin B; Lévêque B; Guilaine J; Bonnefont JP Ann Pediatr (Paris); 1984 Apr; 31(4):311-5. PubMed ID: 6742703 [No Abstract] [Full Text] [Related]
49. 'Face of the giant panda' sign in Wilson's disease: revisited. Kuruvilla A; Joseph S Neurol India; 2000 Dec; 48(4):395-6. PubMed ID: 11146611 [TBL] [Abstract][Full Text] [Related]
50. [Metabolism of iron and copper, action of chelators and therapeutic possibilities in Wilson's disease and hemochromatosis]. PIRART J Pathol Biol; 1961 May; 9():1157-74. PubMed ID: 13735975 [No Abstract] [Full Text] [Related]
51. Treatment of Wilson's disease: the historical background. Walshe JM QJM; 1996 Jul; 89(7):553-5. PubMed ID: 8759497 [No Abstract] [Full Text] [Related]
52. Wilson's disease with extensive degeneration of cerebral white matter and cortex. Shimoji A; Miyakawa T; Watanabe K; Yamashita K; Katsuragi S; Kabashima K Jpn J Psychiatry Neurol; 1987 Dec; 41(4):709-17. PubMed ID: 3453418 [TBL] [Abstract][Full Text] [Related]
53. Antiangiogenic therapy through copper chelation. Sproull M; Brechbiel M; Camphausen K Expert Opin Ther Targets; 2003 Jun; 7(3):405-9. PubMed ID: 12783576 [TBL] [Abstract][Full Text] [Related]